http://www.unboundmedicine.com/medline/ebm/research/darbepoetinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19907192/full_citation/Low_Dose_Darbepoetin_alpha_Attenuates_Progression_of_a_Mouse_Model_of_Aristolochic_Acid_Nephropathy_through_Early_Tubular_Protection_Hamano Y, Aoki T, Shirai R, et al. 
Low-Dose Darbepoetin alpha Attenuates Progression of a Mouse Model of Aristolochic Acid Nephropathy through Early Tubular Protection. [JOURNAL ARTICLE]
Nephron Exp Nephrol 2009 Nov 7; 114(2):e69-e81.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19888948/full_citation/C_E_R_A__once_every_4_weeks_in_patients_with_chronic_kidney_disease_not_on_dialysis:_The_ARCTOS_extension_study_Kessler M, Martínez-Castelao A, Siamopoulos KC, et al. 
C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study. [JOURNAL ARTICLE]
Hemodial Int 2009 Nov 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19880844/full_citation/A_Trial_of_Darbepoetin_Alfa_in_Type_2_Diabetes_and_Chronic_Kidney_Disease_Pfeffer MA, Burdmann EA, Chen CY, et al. 
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. [JOURNAL ARTICLE]
N Engl J Med 2009 Nov 19; 361(21):2019-2032.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19862609/full_citation/Erythropoiesis_Stimulating_Agents_in_Heart_Failure_Patients_with_Anemia:_A_Meta_Analysis_Tehrani F, Dhesi P, Daneshvar D, et al. 
Erythropoiesis Stimulating Agents in Heart Failure Patients with Anemia: A Meta-Analysis. [JOURNAL ARTICLE]
Cardiovasc Drugs Ther 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19858373/full_citation/Darbepoetin_Alfa_and_History_of_Thromboembolic_Events_Ferretti G, Felici A, Cognetti F 
Darbepoetin Alfa and History of Thromboembolic Events. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 20; 27(33):e211.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19856789/full_citation/Effect_of_darbepoetin_alfa_on_renal_anemia_in_Japanese_hemodialysis_patients_Kusaba T, Ishida R, Nakayama M, et al. 
Effect of darbepoetin alfa on renal anemia in Japanese hemodialysis patients. [Journal Article, Research Support, Non-U.S. Gov't]
Arzneimittelforschung 2009; 59(9):435-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19834382/full_citation/Neuroprotective_effect_of_erythropoietin_and_darbepoetin_alfa_after_experimental_intracerebral_hemorrhage_Grasso G, Graziano F, Sfacteria A, et al. 
Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. [Journal Article, Research Support, Non-U.S. Gov't]
Neurosurgery 2009 Oct; 65(4):763-9; discussion 769-70.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19830190/full_citation/Rituximab_therapy_for_pure_red_cell_aplasia_due_to_anti_epoetin_antibodies_in_a_woman_treated_with_epoetin_alfa:_a_case_report_Behler CM, Terrault NA, Etzell JE, et al. 
Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. [Journal Article]
J Med Case Reports 2009.:7335.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19826095/full_citation/Meeting_New_Challenges_in_the_Management_of_Anemia_of_Chronic_Kidney_Disease_Through_Collaborative_Care_with_Pharmacists__November__Bacchus S, O'Mara N, Manley H, et al. 
Meeting New Challenges in the Management of Anemia of Chronic Kidney Disease Through Collaborative Care with Pharmacists (November). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Oct 13.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19815661/full_citation/The_safety_and_tolerability_of_darbepoetin_alfa_in_patients_with_anaemia_and_symptomatic_heart_failure_Klapholz M, Abraham WT, Ghali JK, et al. 
The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure. [JOURNAL ARTICLE]
Eur J Heart Fail 2009 Oct 8.
Abstract | Full Citation | Find Related Articles